Sale of Pope Woodhead

PEMCF provided specialist advice to the directors of Pope Woodhead & Associates throughout the sale process.

/ Completed deal

We are delighted to help Andrew Hobbs and his team with this transaction. The Huron press release is published below.

Global professional services firm Huron announced that it has expanded its life sciences strategy expertise with the acquisition of Pope Woodhead & Associates. The UK-based consulting firm provides market access capabilities to assist clients in developing value propositions for innovative medicines and technologies. The acquisition strengthens the firm’s ability to lead clients through complex payer and regulatory environments across the global healthcare community.

“Life sciences companies are facing tough economic and regulatory environments and are under increasing pressure to justify the value of their innovations to consumers, payers and policymakers,” said James H. Roth, chief executive officer and president of Huron. “Huron and Pope Woodhead’s combined strategic capabilities, market access expertise, deep industry knowledge and global presence enhance our ability to help clients tackle their most pressing problems and deliver measurable results.”

Pope Woodhead, based in Cambridge, partners with the top global pharmaceutical companies as well as biotech and medical device organisations to bring to market therapies that improve patients’ health. The firm’s knowledge of global, regional and local markets and deep understanding of the value of their clients’ innovations have made them a preferred partner of many life sciences organisations.

“Huron is a natural fit for our clients and our employees,” said Andrew Hobbs, chief executive officer of Pope Woodhead, who now becomes a Huron managing director. “Together we will help clients solve their most complex problems by applying our combined expertise to create successful pricing, reimbursement, safety and regulatory strategies.”

For reporting purposes, Pope Woodhead will be included in Huron’s Education and Life Sciences operating segment. Terms of the stock purchase transaction were not disclosed.

For more information, please contact Shaun Nichols, Marketing Co-ordinator at PEM Corporate Finance on 01223 728 280 or